Feb 22, 2024 / 01:30PM GMT
Operator
Good morning and welcome to the Kymera Therapeutics Fourth Quarter 2023 results call. (Operator Instructions) Please not this event is being recorded. I now turn the call over to Justine Koenigsberg.
Thank you.
Justine Koenigsberg - Kymera Therapeutics Inc - VP, IR
Good morning and welcome to Kymera's investor update. Joining me this morning are Nello Mainolfi, Founder, President and CEO; Jared Gollob, our Chief Medical Officer; and Bruce Jacobs, Chief Financial Officer. Following our prepared remarks, we will open the call to questions. We ask that you limit your questions to one and a relevant follow-up to allow enough time to address everyone's questions.
Before we begin, today's discussion will include forward-looking statements about our future expectations, plans and prospects. These statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. A description of these risks can be found in our most recent 10 K filed with the SEC. Any forward-looking statements speak only as of
Q4 2023 Kymera Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot